Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora
- PMID: 35794566
- PMCID: PMC9258144
- DOI: 10.1186/s12967-022-03492-7
Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora
Abstract
In recent years, there has been a greater emphasis on the impact of microbial populations inhabiting the gastrointestinal tract on human health and disease. According to the involvement of microbiota in modulating physiological processes (such as immune system development, vitamins synthesis, pathogen displacement, and nutrient uptake), any alteration in its composition and diversity (i.e., dysbiosis) has been linked to a variety of pathologies, including cancer. In this bidirectional relationship, colonization with various bacterial species is correlated with a reduced or elevated risk of certain cancers. Notably, the gut microflora could potentially play a direct or indirect role in tumor initiation and progression by inducing chronic inflammation and producing toxins and metabolites. Therefore, identifying the bacterial species involved and their mechanism of action could be beneficial in preventing the onset of tumors or controlling their advancement. Likewise, the microbial community affects anti-cancer approaches' therapeutic potential and adverse effects (such as immunotherapy and chemotherapy). Hence, their efficiency should be evaluated in the context of the microbiome, underlining the importance of personalized medicine. In this review, we summarized the evidence revealing the microbiota's involvement in cancer and its mechanism. We also delineated how microbiota could predict colon carcinoma development or response to current treatments to improve clinical outcomes.
Keywords: Bacterial manipulation; Cancer development; Dysbiosis; Microbiome.
© 2022. The Author(s).
Conflict of interest statement
There is no conflict of interests.
Figures
Similar articles
-
Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity.Int J Mol Sci. 2023 Apr 14;24(8):7261. doi: 10.3390/ijms24087261. Int J Mol Sci. 2023. PMID: 37108423 Free PMC article. Review.
-
The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?Cell Mol Gastroenterol Hepatol. 2022;13(3):857-874. doi: 10.1016/j.jcmgh.2021.08.013. Epub 2021 Sep 8. Cell Mol Gastroenterol Hepatol. 2022. PMID: 34506954 Free PMC article. Review.
-
The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.Clin Exp Nephrol. 2017 Feb;21(1):7-15. doi: 10.1007/s10157-016-1255-y. Epub 2016 Mar 10. Clin Exp Nephrol. 2017. PMID: 26965149 Review.
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Prebiotic effects: metabolic and health benefits.Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363. Br J Nutr. 2010. PMID: 20920376 Review.
Cited by
-
From microbes to medicine: harnessing the gut microbiota to combat prostate cancer.Microb Cell. 2024 May 23;11:187-197. doi: 10.15698/mic2024.05.824. eCollection 2024. Microb Cell. 2024. PMID: 38803512 Free PMC article.
-
Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis.Cancers (Basel). 2024 May 18;16(10):1923. doi: 10.3390/cancers16101923. Cancers (Basel). 2024. PMID: 38792001 Free PMC article.
-
Exploring the impact of breast cancer on colonization resistance of mouse microbiota using network node manipulation.Heliyon. 2024 May 11;10(10):e30914. doi: 10.1016/j.heliyon.2024.e30914. eCollection 2024 May 30. Heliyon. 2024. PMID: 38784541 Free PMC article.
-
Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy.Nat Commun. 2024 May 21;15(1):4343. doi: 10.1038/s41467-024-48661-y. Nat Commun. 2024. PMID: 38773197 Free PMC article.
-
Evaluating Oral Probiotic Supplements as Complementary Treatment in Advanced Lung Cancer Patients Receiving ICIs: A Prospective Real-World Study.Cancer Control. 2024 Jan-Dec;31:10732748241253959. doi: 10.1177/10732748241253959. Cancer Control. 2024. PMID: 38736182 Free PMC article.
References
-
- Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107(26):11971–11975. doi: 10.1073/pnas.1002601107. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources